Get the Stockscreener App
3.57
8.46%
-0.33
After Hours:
3.52
-0.05
-1.40%
Avalon Globocare Corp stock is traded at $3.57, with a volume of 50,174.
It is down -8.46% in the last 24 hours and down -26.99% over the past month.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
See More
Previous Close:
$3.90
Open:
$3.86
24h Volume:
50,174
Relative Volume:
0.68
Market Cap:
$6.26M
Revenue:
$1.31M
Net Income/Loss:
$-14.73M
P/E Ratio:
-0.1787
EPS:
-19.98
Net Cash Flow:
$-4.69M
1W Performance:
-4.55%
1M Performance:
-26.99%
6M Performance:
+35.23%
1Y Performance:
-27.66%
1-Day Range:
$3.52
$3.90
1-Week Range:
$3.50
$5.25
52-Week Range:
$2.11
$21.60
Avalon Globocare Corp Stock (ALBT) Company Profile
Name
Avalon Globocare Corp
Sector
Industry
Phone
732-780-4400
Address
4400 ROUTE 9, FREEHOLD
Compare ALBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALBT
Avalon Globocare Corp
|
3.57 | 6.26M | 1.31M | -14.73M | -4.69M | -19.98 |
|
CBRE
Cbre Group Inc
|
117.62 | 35.69B | 35.77B | 968.00M | 1.40B | 3.14 |
|
CSGP
Costar Group Inc
|
79.70 | 33.54B | 2.74B | 138.70M | -245.30M | 0.35 |
|
BEKE
Ke Holdings Inc Adr
|
19.03 | 23.20B | 12.30B | 566.18M | 1.32B | 0.4805 |
|
JLL
Jones Lang Lasalle Inc
|
211.12 | 10.23B | 22.50B | 478.00M | 411.90M | 9.89 |
|
FSV
Firstservice Corp
|
172.03 | 7.67B | 4.93B | 108.16M | 203.45M | 2.40 |
Avalon Globocare Corp Stock (ALBT) Latest News
Head-To-Head Contrast: Avalon GloboCare (NASDAQ:ALBT) and Black Diamond Therapeutics (NASDAQ:BDTX) - Defense World
Avalon (ALBT) Expands with SpecialtyHealth Partnership | ALBT St - GuruFocus
Avalon GloboCare Partners with SpecialtyHealth for Fitness Initiative - TipRanks
Avalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs’ Fitness Challenge with KetoAir - GlobeNewswire
Revolutionary Health Tech: Police Chiefs Nationwide Adopt KetoAir Smart Ketone Monitor - Stock Titan
Avalon GloboCare Announces Issuance of Patent for Novel CAR-T an - GuruFocus
Avalon GloboCare secures patent for CAR-T, CAR-NK technology in China By Investing.com - Investing.com South Africa
Avalon (ALBT) Stock Advances On Breakthrough Patent News - Stocks Telegraph
Avalon Globocare Announces Issuance Of Patent In China - marketscreener.com
Avalon GloboCare secures patent for CAR-T, CAR-NK technology in China - Investing.com Australia
Avalon GloboCare Secures Patent for CAR-T Technology - TipRanks
Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China - GlobeNewswire
Game-Changing Cancer Treatment Patent: Dual-Target CAR-T Tech Secures 20-Year China Protection - Stock Titan
Avalon GloboCare Corp. (NASDAQ:ALBT) Stock Holdings Lessened by Virtu Financial LLC - Defense World
Avalon GloboCare Partners with Pounds for Health Challenge - TipRanks
Avalon GloboCare Partners with Pounds Transformation Clinics to Unveil the KetoAir BrAce 4 Impact Challenge Series - The Manila Times
Avalon partners with Pounds Transformation Clinics for KetoAir - TipRanks
Avalon GloboCare Corp. SEC 10-K Report - TradingView
Avalon GloboCare Corp. (ALBT) reports earnings - qz.com
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Down 47.6% in March - Defense World
Short Interest in Avalon GloboCare Corp. (NASDAQ:ALBT) Rises By 358.6% - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN and ALBT on Behalf of Shareholders - Finansavisen
ALBT Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Avalon GloboCare Corp. is Fair to - EIN News
ALBT Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Avalon GloboCare Corp. is Fair to Shareholders - The Bakersfield Californian
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Avalon GloboCare Corp.ALBT - PR Newswire
The Ademi Firm investigates whether Avalon GloboCare Corp. is obtaining a Fair Price for its Public Shareholders - Business Wire
Shareholder Alert: The Ademi Firm investigates whether Avalon GloboCare Corp. is obtaining a Fair Price for its Public Shareholders - Joplin Globe
Avalon Globocare and Yoov to merge -March 10, 2025 at 10:45 am EDT - Marketscreener.com
Avalon GloboCare and YOOV To Merge - citybiz
Avalon GloboCare Announces Merger with YOOV Group - TipRanks
Avalon announces merger with AI firm YOOV, sees revenue surge - Investing.com India
Avalon GloboCare, YOOV Group Holding enter merger agreement - TipRanks
Avalon announces merger with AI firm YOOV, sees revenue surge By Investing.com - Investing.com Australia
Avalon GloboCare and YOOV, a Leading Business AI Automation Solutions Provider, Enter into Merger Agreement - GlobeNewswire
Avalon GloboCare Announces Merger: AI Firm YOOV Reports 59% Growth - StockTitan
(ALBT) Trading Signals - Stock Traders Daily
Short Interest in Avalon GloboCare Corp. (NASDAQ:ALBT) Rises By 37.5% - Defense World
Avalon GloboCare finalizes equity interest redemption deal By Investing.com - Investing.com South Africa
Avalon GloboCare finalizes equity interest redemption deal - Investing.com India
Avalon GloboCare (NASDAQ: ALBT) Receives Notice of Allowance for Innovative CAR-T and CAR-NK Cell Technology in ChinaFREEHOLD, N.J., February 18, 2025 – Avalon GloboCare Corp. (NASDAQ: ALBT), a leading developer of precision diagnostics a - Defense World
Avalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell Technology in China - GlobeNewswire
Avalon GloboCare Receives Notice of Allowance for Chimeric Antigen Receptor Cell Technology in China - Marketscreener.com
Avalon GloboCare secures patent in China for CAR therapy tech By Investing.com - Investing.com South Africa
Avalon GloboCare secures patent in China for CAR therapy tech - Investing.com
Revolutionary Cancer Treatment Patent: Avalon's Dual-Target CAR-T Therapy Gets China's Green Light - StockTitan
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update - Defense World
Head to Head Analysis: Sangamo Therapeutics (NASDAQ:SGMO) versus Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare announces preferred stock exchange and amendment By Investing.com - Investing.com Australia
Avalon GloboCare announces preferred stock exchange and amendment - Investing.com India
Avalon Globocare Corp Stock (ALBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.56%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):